Second engineered B cell therapy enters the clinic, promising to do in hemophilia B what gene therapies can't
In a first, the FDA cleared a B cell therapy for clinical testing in hemophilia B in the latest step forward for a new approach …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
